![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.uspharmacist.com/CMSImagesContent/2011/5/USD1101-GLP-F1.gif)
oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]
Description
GastaldelliAGagginiMDanieleGCiociaroDCersosimoETripathyDet al
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Class 3: Sitagliptin, anagliptin, gemigliptin, and teneligliptin bind at the S2-extensive site and show the strongest inhibition potentials [17], [20]
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://substackcdn.com/image/fetch/$s_!PZQl!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F25ddad2d-af6a-498f-a83a-761ac15a3a68_1306x1010.png)
Medication dosing also plays a role
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.diabetesincontrol.com/wp-content/uploads/2026/01/oral-glp1-therapy-type2-diabetes-pills-glucose-control.png)
A., Aguila M
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/234000454/figure/tbl1/AS:601727753539599@1520474484695/Dosage-of-GLP-1-analogues.png)
35,36 Although some studies report smaller reductions in muscle mass, many scientists argue that these findings should not be ignored due to the high metabolic rate of skeletal muscle which plays an important role in maintaining significant weight loss
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05715-4/MediaObjects/125_2022_5715_Figa_HTML.png)
Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited
![oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://journalce.powerpak.com/courses/118759/CE_Semaglutide_Table1.gif)
